Results 121 to 130 of about 24,116 (179)

Human immunodeficiency virus vaccines: Advances, challenges and future perspectives. [PDF]

World J Virol
Varatharajan S, Krishnasai S, Girish C.
europepmc   +1 more source

ALFQ adjuvanted HIV-1 envelope protein vaccination elicits durable functional antibody and cellular responses in nonhuman primates. [PDF]

NPJ Vaccines
Shrivastava S, Carmen JM, Kim J, Peachman KK, Basu S, Alving R, Nettere D, Kundu G, Yum L, Rahman MA, Jha S, Trinh HV, Rosado L, Nguyen P, Morrison E, Swafford I, Machmach K, Bolton JS, Yates A, Misicka E, Beck Z, Mutascio S, Jobe O, Zemil McCrea M, Wieczorek L, Bergmann-Leitner ES, Polonis V, Paquin-Proulx D, Pollara J, Matyas GR, Alving CR, Thomas R, Franchini G, Ferrari G, Haynes BF, Ake JA, Rao M.   +36 more
europepmc   +1 more source

Turning defense into damage: HIV-driven amyloidogenesis and neurotoxicity. [PDF]

mBio
Gu F, Saed B, Naghavi MH.
europepmc   +1 more source

Targeting of specific CCR5-G protein complexes underlies biased signaling by HIV-1 envelope glycoproteins. [PDF]

Cell Commun Signal
Gasser R, Colin P, Jacquemard C, Montagné T, Zhou Z, Pons V, Kostenis E, Galés C, Kellenberger E, Lagane B.   +9 more
europepmc   +1 more source

Recent Nanotherapeutic Advancements Against HIV-Associated Neurocognitive Disorders (HAND). [PDF]

Biomolecules
Trivedi R, Gothwal A, Layek B, Singh J.
europepmc   +1 more source

Experimental and MEDT Study of Sydnone-Alkyne Cycloaddition-Based Synthesis of 1,4-Disubstituted Pyrazoles and In Silico Investigation of Their Binding to HCV and HIV Proteins. [PDF]

Molecules
Zerbib S, Eddahmi M, Alaqarbeh M, Bodet PE, Thiery V, Fatimi A, Cruz-Martins N, Bailly C, Domingo LR, Bouissane L.   +9 more
europepmc   +1 more source

Characterization of full-length and cytoplasmic tail-truncated envelope glycoproteins incorporated into human immunodeficiency virus (HIV-1) virions and virus-like particles. [PDF]

J Virol
Anang S, Zhang S, Ennis A, Ding H, Deshpande A, Nguyen HT, Kappes JC, Sodroski JG.   +7 more
europepmc   +1 more source

Genotypic and phenotypic characteristics of CXCR4-using transmitted/founder HIV-1 envelope glycoproteins. [PDF]

J Virol
Martres D, Montagné T, Pani S, Jeanne N, Armani-Tourret M, Requena M, Vellas C, Raymond S, Lorin V, Gallois Y, Puissant-Lubrano B, Mouquet H, Delobel P, Izopet J, Lagane B.   +14 more
europepmc   +1 more source

Modeling Human Protein Physical Interactions Involved in HIV Attachment In Silico. [PDF]

Int J Mol Sci
Davydenko VS, Shchemelev AN, Ostankova YV, Anufrieva EV, Totolian AA.   +4 more
europepmc   +1 more source